Advanced search
Publication Cover
Clinical Interventions in Aging Volume 4, 2009 - Issue
Submit an article Journal homepage
111
Views
3
CrossRef citations to date
0
Altmetric
Review

Once-yearly zoledronic acid in hip fracture prevention

Oddom DemontieroAging Bone Research Program, Nepean Clinical School, University of Sydney, Penrith, NSW, Australia;Department of Geriatric Medicine, Nepean Hospital, Penrith, NSW, Australia
&
Gustavo DuqueAging Bone Research Program, Nepean Clinical School, University of Sydney, Penrith, NSW, Australia;Department of Geriatric Medicine, Nepean Hospital, Penrith, NSW, AustraliaCorrespondence[email protected]
Pages 153-164 | Published online: 25 Mar 2009

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Johann D Ringe. (2010) Development of clinical utility of zoledronic acid and patient considerations in the treatment of osteoporosis. Patient Preference and Adherence 4, pages 231-245.
Read now
Ray Marks. (2010) Hip fracture epidemiological trends, outcomes, and risk factors, 1970–2009. International Journal of General Medicine 3, pages 1-17.
Read now
Ronald C Hamdy. (2010) Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass. Drug Design, Development and Therapy 4, pages 321-335.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.